EGFR and PAR2 regulation of intestinal permeability

Details for Australian Patent Application No. 2010259213 (hide)

Owner UNIVERSITY OF MARYLAND, BALTIMORE

Inventors Fasano, Alessio; Lammers, Karen; Shea-Donohue, Terez; Goldblum, Simeon

Agent Baxter IP

Pub. Number AU-A-2010259213

PCT Pub. Number WO2010/144140

Priority 61/185,662 10.06.09 US

Filing date 10 June 2010

Wipo publication date 16 December 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/144140 Priority application(s): WO2010/144140

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010259222-Process for enhanced remediation of contaminated wastewaters, soils and wasteforms

2010259207-Method of delivering a thermoplastic and/or crosslinking resin to a composite laminate structure